MONTVALE, N.J., April 4 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. today announced that Jim Sulat, President and Chief Executive Officer, will provide a company update at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference on Wednesday, April 11, 2007, at 1:20 p.m. Eastern Time at the Millennium Broadway Hotel in New York City.
Interested parties may access a live audio webcast of the presentations by visiting the “Investors” section of Memory Pharmaceuticals’ website at http://www.memorypharma.com. Archived versions of the webcast will be available at the same location for one week following the presentation.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer’s disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at http://www.memorypharma.com.
Memory Pharmaceuticals Corp.
CONTACT: Jzaneen Lalani, Vice President, Legal Affairs, +1-201-802-7249;or Laura Perry, Stern Investor Relations, Inc., +1-212-362-1200
Web site: http://www.memorypharma.com/
